Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

TNGX

Showing 6 of 15 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in Tango Therapeutics, Inc.

Yes. Janus Henderson holds 2,394,972 shares of TNGX (Tango Therapeutics), worth $50.1M, as of its Q1 2026 13F filing. It reduced the position by 249,265 shares (-9.4%) from Q4 2025. Janus Henderson has held TNGX since Q3 2025, across 3 quarterly 13F filings.

Current Value

$50.1M

Current Shares

2.4M

Total Value Change

+$50M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
2.4M
-9.4%
$50.1M0.0%$20.92
0
2025-Q4
Increased
2.6M
+14.8%
$23.5M0.0%$8.86
33
2025-Q3
New
2.3M
-
$19.3M0.0%$8.40
39
2025-Q1
Exited
0
-100.0%
$00.0%$1.37
0
2024-Q4
Unchanged
11,631
0.0%
$35,8820.0%$3.09
0
2024-Q3
Unchanged
11,631
0.0%
$89,6170.0%$7.47
0

Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used